Document is current
Any future updates will be listed below
-
Authors
Matsui, Sadako https://orcid.org/0000-0002-0117-266X
Hiraishi, Chika
Sato, Ryo
Kojima, Takai
Matoba, Keiichiro
Fujimoto, Kei
Yoshida, Hiroshi
-
Funding
Funding for this research was provided by:
Japan Ministry of Education, Culture, Sports, Science, and Technology (17K09560)
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 20 January 2025
First Online: 8 February 2025
Declarations
:
: Hiroshi Yoshida received honoraria from Denka and Kowa Company and a manuscript fee from Kowa Company. Kei Fujimoto received honoraria from Eli Lilly Japan and Sumitomo Pharma and subsidies or donations from Nippon Boehringer Ingelheim and Mitsubishi Chemical Group. Sadako Matsui, Chika Hiraishi, Ryo Sato, Takai Kojima, and Keiichiro Matoba declare no conflict of interest.
: This study conformed to the ethical guidelines for medical and health research involving human subjects and was approved by the Ethics Committee of the Jikei University School of Medicine (approval dates: May 5, 2018, and May 17, 2021; approval number: 30–010).
: A waiver for informed consent was approved with opt-out consent. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and/or with the Helsinki Declaration of 1964 and later versions. The institution waived the requirement of informed consent but approved opt-out consent.
